Steven A. Curley

Simplified staging for hepatocellular carcinoma.

Activation of Src kinase in primary colorectal carcinoma: an indicator of poor clinical prognosis.

High frequency loss of heterozygosity in von Hippel-Lindau (VHL)-associated and sporadic pancreatic islet cell tumors: evidence for a stepwise mechanism for malignant conversion in VHL tumorigenesis.

Radiofrequency ablation of hepatic metastases.

Preoperative predictors of survival after resection of small hepatocellular carcinomas.

Predictors of microvascular invasion in patients with hepatocellular carcinoma who are candidates for orthotopic liver transplantation.

Radiofrequency ablation of primary and metastatic hepatic malignancies.

Advances in the treatment of liver tumors.

Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization.

Targeted expression of green fluorescent protein/tumor necrosis factor-related apoptosis-inducing ligand fusion protein from human telomerase reverse transcriptase promoter elicits antitumor activity without toxic effects on primary human hepatocytes.

Role of Rel/NF-kappaB transcription factors in apoptosis of human hepatocellular carcinoma cells.

Radiofrequency ablation of primary and metastatic liver tumors.

Pain and quality of life after treatment in patients with locally recurrent rectal cancer.

Long-term tumor-free survival from treatment with the GFP-TRAIL fusion gene expressed from the hTERT promoter in breast cancer cells.

Prolonged stability and sustained prodrug cell killing activity using receptor-mediated delivery of malarial circumsporozoite-cytosine deaminase fusion protein into liver cancer cells.

Phase II trial of systemic continuous fluorouracil and subcutaneous recombinant interferon Alfa-2b for treatment of hepatocellular carcinoma.

Radiofrequency ablation of malignant liver tumors.

Feasibility of adjuvant hepatic arterial infusion of chemotherapy after radiofrequency ablation with or without resection in patients with hepatic metastases from colorectal cancer.

Complication, local recurrence, and survival rates after radiofrequency ablation for hepatic malignancies.

Regression of hepatocellular cancer in a patient treated with arginine deiminase.

Comparison of clinicopathologic characteristics and outcomes after resection in patients with hepatocellular carcinoma treated in the United States, France, and Japan.

Combined resection and radiofrequency ablation for advanced hepatic malignancies: results in 172 patients.

Perioperative complications in patients undergoing major liver resection with or without neoadjuvant chemotherapy.

Radiofrequency ablation: the experts weigh in.

Predicting the node-negative mesorectum after preoperative chemoradiation for locally advanced rectal carcinoma.

Incidence and distribution of argininosuccinate synthetase deficiency in human cancers: a method for identifying cancers sensitive to arginine deprivation.

Surgical treatment of colorectal cancer metastasis.

Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients.

Is extended hepatectomy for hepatobiliary malignancy justified?

A prospective evaluation of radiocolloid and immunohistochemical staining in colon carcinoma lymphatic mapping.

Pegylated arginine deiminase treatment of patients with unresectable hepatocellular carcinoma: results from phase I/II studies.

Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases.

Oral capecitabine for the treatment of hepatocellular carcinoma, cholangiocarcinoma, and gallbladder carcinoma.

Critical evaluation of the different staging systems for hepatocellular carcinoma (Br J Surg 2004; 91: 400-408).

Long-term survival after an aggressive surgical approach in patients with breast cancer hepatic metastases.

Transdiaphragmatic radiofrequency ablation of liver tumors.

Hepatitis serology predicts tumor and liver-disease characteristics but not prognosis after resection of hepatocellular carcinoma.

Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: results of a multicenter study.

Ethical issues in surgical palliative care: am I killing the patient by "letting him go"?

Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases.

Critical appraisal of the clinical and pathologic predictors of survival after resection of large hepatocellular carcinoma.

Is hepatic resection for large or multinodular hepatocellular carcinoma justified? Results from a multi-institutional database.

Significant long-term survival after radiofrequency ablation of unresectable hepatocellular carcinoma in patients with cirrhosis.

A prospective evaluation of ultrasound-directed transparenchymal vascular control with linear cutting staplers in major hepatic resections.

Surgical resection after downsizing of colorectal liver metastasis in the era of bevacizumab.

The role of focal liver ablation in the treatment of unresectable primary and secondary malignant liver tumors.

One surgeon's unabashedly biased view on liver resection.

Neoadjuvant chemotherapy for metastatic colon cancer: a cautionary note.

Comparison between hepatic wedge resection and anatomic resection for colorectal liver metastases.

Outcome after curative resection for locally recurrent rectal cancer.

Outcomes after surgical treatment of colorectal cancer liver metastases.

Debunking dogma: surgery for four or more colorectal liver metastases is justified.

Accuracy of preoperative imaging of hepatic tumors with helical computed tomography.

Hepatic resection for metastatic melanoma: distinct patterns of recurrence and prognosis for ocular versus cutaneous disease.

Abdominal visceral lesions in von Hippel-Lindau disease: incidence and clinical behavior of pancreatic and adrenal lesions at a single center.

Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases.

Solitary colorectal liver metastasis: resection determines outcome.

Retrospective study of capecitabine and celecoxib in metastatic colorectal cancer: potential benefits and COX-2 as the common mediator in pain, toxicities and survival?

Results of a single-center experience with resection and ablation for sarcoma metastatic to the liver.

Hepatobiliary cancers. Clinical practice guidelines in oncology.

Mammalian pharmacokinetics of carbon nanotubes using intrinsic near-infrared fluorescence.

Pegylated arginine deiminase lowers hepatitis C viral titers and inhibits nitric oxide synthesis.

Resection of hepatic colorectal metastases involving the caudate lobe: perioperative outcome and survival.

Comparison of CT methods for determining the fat content of the liver.

Pilot study of regional, hepatic intra-arterial paclitaxel in patients with breast carcinoma metastatic to the liver.

Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy.

High-resolution computed tomography accurately predicts resectability in hilar cholangiocarcinoma.

Liver-directed surgery for metastatic squamous cell carcinoma to the liver: results of a multi-center analysis.

Systemic chemotherapy and two-stage hepatectomy for extensive bilateral colorectal liver metastases: perioperative safety and survival.

Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial?

Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases.

Carbon nanotube-enhanced thermal destruction of cancer cells in a noninvasive radiofrequency field.

Intracellular gold nanoparticles enhance non-invasive radiofrequency thermal destruction of human gastrointestinal cancer cells.

Selection for resection of hepatocellular carcinoma and surgical strategy: indications for resection, evaluation of liver function, portal vein embolization, and resection.

Efficacy of a haemostatic matrix for the management of bleeding in patients undergoing liver resection: results from 237 cases.

Re: Right hepatic trisectionectomy for hepatobiliary disease: results and an appraisal of its current role.

Effect of different types of smoking and synergism with hepatitis C virus on risk of hepatocellular carcinoma in American men and women: case-control study.

Preoperative bevacizumab does not significantly increase postoperative complication rates in patients undergoing hepatic surgery for colorectal cancer liver metastases.

Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases.

The association of family history of liver cancer with hepatocellular carcinoma: a case-control study in the United States.

Indicators of surgery and survival in oncology inpatients requiring surgical evaluation for palliation.

Assessment tools in the training of surgical oncologists: educating trainees and educators.

Noninvasive radiofrequency field-induced hyperthermic cytotoxicity in human cancer cells using cetuximab-targeted gold nanoparticles.

Major hepatic resection for hepatocellular carcinoma with or without portal vein embolization: Perioperative outcome and survival.

Association between hypothyroidism and hepatocellular carcinoma: a case-control study in the United States.

NCCN clinical practice guidelines in oncology: hepatobiliary cancers.

Three hundred and one consecutive extended right hepatectomies: evaluation of outcome based on systematic liver volumetry.

Two-surgeon technique of parenchymal transection contributes to reduced transfusion rate in patients undergoing major hepatectomy: analysis of 1,557 consecutive liver resections.

Can hepatocellular cancer screening increase the proportion of long-term survivors?

Targeted hyperthermia using metal nanoparticles.

HCV-related hepatocellular carcinoma: From chronic inflammation to cancer.

Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases.

A protocol to effectively create single cell suspensions of adherent cells for multiparameter high-throughput flow cytometry.

Replacing Mn(2+) with Co(2+) in human arginase i enhances cytotoxicity toward l-arginine auxotrophic cancer cell lines.

Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma.

Use of nanoparticles for targeted, noninvasive thermal destruction of malignant cells.

Phase II study of pegylated arginine deiminase for nonresectable and metastatic hepatocellular carcinoma.

Effectiveness of positron emission tomography for predicting chemotherapy response in colorectal cancer liver metastases.

Bioengineered arginase I increases caspase-3 expression of hepatocellular and pancreatic carcinoma cells despite induction of argininosuccinate synthetase-1.

Surgical strategies for synchronous colorectal liver metastases in 156 consecutive patients: classic, combined or reverse strategy?

Pancreatic carcinoma cells are susceptible to noninvasive radio frequency fields after treatment with targeted gold nanoparticles.

Radiofrequency field-induced thermal cytotoxicity in cancer cells treated with fluorescent nanoparticles.

Extended preoperative chemotherapy does not improve pathologic response and increases postoperative liver insufficiency after hepatic resection for colorectal liver metastases.

Long-term survival after surgical management of neuroendocrine hepatic metastases.

Biodistribution and acute toxicity of naked gold nanoparticles in a rabbit hepatic tumor model.

Radiofrequency ablation leads to excellent local tumor control and durable longterm survival in specific subsets of early stage HCC patients confirming to the Milan criteria.

Noninvasive radiofrequency field destruction of pancreatic adenocarcinoma xenografts treated with targeted gold nanoparticles.

High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome.

Case records of the Massachusetts General Hospital: Case 3-2011: a 58-year-old woman with a mass in the liver.

Ablative procedures in surgical oncology. Preface.

The ongoing history of thermal therapy for cancer.

Is resection of colorectal liver metastases after a second-line chemotherapy regimen justified?

Bioengineered human arginase I with enhanced activity and stability controls hepatocellular and pancreatic carcinoma xenografts.

Improved survival after resection of liver and lung colorectal metastases compared with liver-only metastases: a study of 112 patients with limited lung metastatic disease.

Identification of cancer stem cells in human gastrointestinal carcinoid and neuroendocrine tumors.

APOBEC3G promotes liver metastasis in an orthotopic mouse model of colorectal cancer and predicts human hepatic metastasis.

Non-invasive radiofrequency-induced targeted hyperthermia for the treatment of hepatocellular carcinoma.

Repeat hepatectomy for recurrent colorectal liver metastases is associated with a high survival rate.

Multiple kinase pathways involved in the different de novo sensitivity of pancreatic cancer cell lines to 17-AAG.

Internalization of C60 fullerenes into cancer cells with accumulation in the nucleus via the nuclear pore complex.

Resection of liver metastases from breast cancer: estrogen receptor status and response to chemotherapy before metastasectomy define outcome.

Liver resection for liver metastases from nondigestive endocrine cancer: extrahepatic disease burden defines outcome.

Stability of antibody-conjugated gold nanoparticles in the endolysosomal nanoenvironment: implications for noninvasive radiofrequency-based cancer therapy.

Silencing thioredoxin induces liver cancer cell senescence under hypoxia.

Hepatectomy for noncolorectal non-neuroendocrine metastatic cancer: a multi-institutional analysis.

Luciferase-based protein denaturation assay for quantification of radiofrequency field-induced targeted hyperthermia: developing an intracellular thermometer.

Hepatic stem cells and transforming growth factor β in hepatocellular carcinoma.

Risk of venous thromboembolism outweighs post-hepatectomy bleeding complications: analysis of 5651 National Surgical Quality Improvement Program patients.

Neither neoadjuvant nor adjuvant therapy increases survival after biliary tract cancer resection with wide negative margins.

Non-invasive radiofrequency ablation of malignancies mediated by quantum dots, gold nanoparticles and carbon nanotubes.

Morbidity of staged proctectomy after hepatectomy for colorectal cancer: a matched case-control analysis.

Improved long-term survival after major resection for hepatocellular carcinoma: a multicenter analysis based on a new definition of major hepatectomy.

Greater complexity of liver surgery is not associated with an increased incidence of liver-related complications except for bile leak: an experience with 2,628 consecutive resections.

Adjuvant chemotherapy with FOLFOX for primary colorectal cancer is associated with increased somatic gene mutations and inferior survival in patients undergoing hepatectomy for metachronous liver metastases.

Optimal morphologic response to preoperative chemotherapy: an alternate outcome end point before resection of hepatic colorectal metastases.

Kinetic Growth Rate after Portal Vein Embolization Predicts Posthepatectomy Outcomes: Toward Zero Liver-Related Mortality in Patients with Colorectal Liver Metastases and Small Future Liver Remnant.

Remotely triggered cisplatin release from carbon nanocapsules by radiofrequency fields.

Association of diabetes and perineural invasion in pancreatic cancer.

Optimal future liver remnant in patients treated with extensive preoperative chemotherapy for colorectal liver metastases.

Margin status remains an important determinant of survival after surgical resection of colorectal liver metastases in the era of modern chemotherapy.

Prospective screening increases the detection of potentially curable hepatocellular carcinoma: results in 8900 high-risk patients.

A physical sciences network characterization of non-tumorigenic and metastatic cells.

Analysis of the efficacy of portal vein embolization for patients with extensive liver malignancy and very low future liver remnant volume, including a comparison with the associating liver partition with portal vein ligation for staged hepatectomy approach.

Cytotoxicity and variant cellular internalization behavior of water-soluble sulfonated nanographene sheets in liver cancer cells.

Citrate-capped gold nanoparticle electrophoretic heat production in response to a time-varying radiofrequency electric-field.

Intrabiliary Growth of Liver Metastases: Clinicopathologic Features, Prevalence, and Outcome.

Modified cisplatin/interferon α-2b/doxorubicin/5-fluorouracil (PIAF) chemotherapy in patients with no hepatitis or cirrhosis is associated with improved response rate, resectability, and survival of initially unresectable hepatocellular carcinoma.

Aspergillus fumigatus Hyphal Damage Caused by Noninvasive Radiofrequency Field-Induced Hyperthermia.

Porous silicon advances in drug delivery and immunotherapy.

Tumor selective hyperthermia induced by short-wave capacitively-coupled RF electric-fields.

Distinct predictors of pre- versus post-discharge venous thromboembolism after hepatectomy: analysis of 7621 NSQIP patients.

Mechanistic patient-specific predictive correlation of tumor drug response with microenvironment and perfusion measurements.